Quantbot Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quantbot Technologies’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,658	Closed	-$98.8K	–	2066
2023 Q1	$98.8K	Buy	+2,658	New	+$120K	0.01%	1093
2021 Q3	–	Sell	-127	Closed	-$20K	–	2023
2021 Q2	$20K	Sell	127 -828	-87%	-$133K	﹤0.01%	1222
2021 Q1	$163K	Sell	955 -545	-36%	-$108K	0.02%	766
2020 Q4	$329K	Sell	1,500 -471	-24%	-$102K	0.03%	519
2020 Q3	$327K	Buy	+1,971	New	+$270K	0.04%	460
2019 Q4	–	Sell	-300	Closed	-$23K	–	1672
2019 Q3	$23K	Sell	300 -100	-25%	-$9.38K	﹤0.01%	1097
2019 Q2	$41K	Buy	+400	New	+$31.1K	﹤0.01%	934
2018 Q3	–	Sell	-470	Closed	-$23K	–	1622
2018 Q2	$23K	Sell	470 -4,654	-91%	-$176K	﹤0.01%	1071
2018 Q1	$157K	Buy	+5,124	New	+$142K	0.01%	743

Other funds holding MRTX

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Quantbot Technologies's MRTX Position: Q2 2023 in Review

Quantbot Technologies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 2,658 shares — an estimated $98.8K sold.

Quantbot Technologies first reported a position in MRTX in Q1 2018 and held it in 9 quarters. The position peaked at $329K in Q4 2020. 205 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

Quantbot Technologies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Quantbot Technologies sold 2,658 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $98.8K.
Quantbot Technologies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Quantbot Technologies's Mirati Therapeutics, Inc. Common Stock position peaked at $329K in Q4 2020.
205 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.